Risk Factors Associated With Isolation of Stenotrophomonas (Xanthomonas) maltophilia in Clinical Specimens
- 1 May 1997
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 18 (5) , 316-321
- https://doi.org/10.1086/647618
Abstract
To determine risk factors for patients whose cultures grew Stenotrophomonas maltophilia. Retrospective case-control study of 60 patients with cultures positive for S maltophilia, matched by specimen site to 120 controls whose cultures grew other gram-negative aerobic bacteria. University medical center. S maltophilia was identified from the following sites: respiratory (36), wound (13), urinary (6), blood (4), and cerebral spinal fluid (1). By univariate analysis, cases had a higher risk of exposure than controls for ampicillin (P < .001), gentamicin (P < .001), vancomycin (P = .001), metronidazole (P = .003), piperacillin (P = .007), cefotaxime (P = .014), ceftazidime (P = .017), ciprofloxacin (P = .030), tobramycin (P = .040), and chronic respiratory disease (P = .024). Length of time foreign objects were in place prior to positive culture differed significantly between cases and controls only for endotracheal tubes in patients with respiratory isolates (median number of days: 12.5 for cases, 5 for controls; P = .007). For patients with urinary tract infections, having a urinary catheter increased the odds of infection 10 times over controls. Exposures found by multivariate analysis to be significantly more prevalent in cases than controls included ampicillin, cefotaxime, erythromycin, gentamicin, metronidazole, piperacillin, tobramycin, chronic respiratory disease, and female gender. Odds ratios were > 1 indicating higher risk for cases, except for erythromycin, which had an odds ratio < 1. The primary risk factor associated with isolation of S maltophilia was antibiotic use. For patients with pulmonary infections, chronic respiratory disease and length of time an endotracheal tube was in place also contributed to the risk. This suggests that judicious use of antibiotics may prevent some cases of S maltophilia infection.Keywords
This publication has 25 references indexed in Scilit:
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centreJournal of Hospital Infection, 1992
- Infections Due to Xanthomonas maltophilia in Patients with Hematologic MalignancyClinical Infectious Diseases, 1991
- Antibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinationsDiagnostic Microbiology and Infectious Disease, 1991
- Nosocomial Infections Due to Xanthomonas maltophilia (Pseudomonas maltophilia) in Patients with CancerClinical Infectious Diseases, 1990
- Septicemia Due to Xanthomonas Species and Non-Aeruginosa Pseudomonas SpeciesMedicine, 1990
- Pediatric risk of mortality (PRISM) scoreCritical Care Medicine, 1988
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- In-vitro susceptibility of Pseudomonas species to fifteen antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1987
- APACHE IICritical Care Medicine, 1985